XML 97 R80.htm IDEA: XBRL DOCUMENT v3.25.0.1
Fair Value of Financial Instruments - Additional Information (Detail)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2019
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Long-term Investments $ 75,414   $ 69,712 $ 75,414    
Debt and Equity Securities, Unrealized Gain (Loss)     $ 0 $ (26,262) $ 26,964  
Contingent Consideration Liability [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Debt Instrument, Measurement Input 0.063   0.056 0.063    
Convertible Debt Securities [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Debt Instrument, Maturity Date     Jan. 17, 2027      
Convertible Debt Securities [Member] | Shorelight Holdings Llc [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Long-term Investments     $ 40,900      
Debt Instrument, Interest Rate, Stated Percentage     1.69%      
Convertible Debt Securities [Member] | Shorelight Holdings Llc [Member] | Measurement Input, Price Volatility            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Debt Instrument, Measurement Input 0.350   0.400 0.350    
Convertible Debt Securities [Member] | Shorelight Holdings Llc [Member] | Measurement Input, Discount Rate            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Debt Instrument, Measurement Input 0.245   0.235 0.245    
Preferred Stock [Member] | Medically Home Group Inc. [Member]            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Long-term Investments           $ 5,000
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount $ 26,300          
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount     $ 26,300      
Equity Securities without Readily Determinable Fair Value, Amount $ 7,400   7,400 $ 7,400    
Debt and Equity Securities, Unrealized Gain (Loss)   $ 27,000        
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount     $ 28,600